Eduardo Pisani became Director General of IFPMA at the end of 2009. He came to the IFPMA from Bristol-Myers Squibb, a company he joined in 2001, and in which he had risen to the position of Vice-President, International Policy and Government Affairs. During his time at BMS, Eduardo contributed to the development of policy and access initiatives in major disease areas, as well as to industry associations’ work on key international policy issues. He established the first cross-sectoral industry advocacy group on healthcare policy in Brussels, under the aegis of the American Chamber of Commerce to the EU.
Prior to that, Eduardo held positions as legal counsel at Immuno AG in Brussels and Vienna, at Baxter Healthcare in Belgium and Italy, and in European Policy and Government Affairs at Adamson Associates and SmithKline Beecham in Brussels. He started his career in 1989, in the marketing department of Lederle France.
Policy Analyst, Regulatory Policy and Economic Affairs
Cristina Arnes joined IFPMA in March 2014 and focuses on Biotherapeutics and Socio-Economic Research Network affairs.
Prior to joining IFPMA, she worked for the Irish Pharmaceutical Healthcare Association (IPHA) in the Department of Commercial Affairs and in the Spanish Association of the Pharmaceutical Industry (Farmaindustria) in the Department of International Affairs. Cristina holds a master degree in International Health Management from the Imperial College Business School London and a post-graduate degree in Economics from Universidad San Pablo CEU Madrid (Spain).
Janis Bernat joined IFPMA in 2006 and is responsible for the organization’s work in the area of biotherapeutic medicines. Prior to joining IFPMA, she worked for a multi-national food company in quality assurance and regulatory compliance. She holds degrees in both agriculture and mass communications.
Laetitia Bigger joined IFPMA in 2006 and is responsible for vaccines policy and anti-doping cooperation. She coordinated IFPMA activities related to regulatory policy - clinical trial transparency, ethics in medical research and pediatric medicines - and technical standards for innovative medicines, until December 2011. Prior to joining IFPMA, she worked as clinical research associate for the multidisciplinary center on oncology, University Hospital Lausanne. She holds a PhD degree in Biology from the University of Lausanne (Switzerland).
Martina Bilova joined IFPMA as Administrative Assistant to the Biologicals and Vaccines Committee in November 2007, and since April 2011 she has work as administrative assistant to the IFPMA. She provides administrative support to staff and members of IFPMA, takes care of the logistics of meetings and events, updates the website, Extranet platform and database of IFPMA. Martina previously worked in the administration of import-export companies in Slovakia. She holds the Accounting diploma and Bachelor in Business Administration at the University of Geneva.
Senior Manager, Innovation, Intellectual Property and Trade
Guilherme Cintra joined IFPMA in March 2005 and leads IFPMA’s advocacy with the WTO and the WIPO’s Development Agenda. He also staffs the IFPMA Socio-Economic Research Network, which conducts international research and analytical work on different subjects relating to intellectual property, pharmaceutical innovation and access to medicines.
Prior to this position, he was responsible for monitoring industry’s access initiatives in the developing world and provided analytical and administrative support to different groups at IFPMA. He has also worked as European liaison on several carbon credits projects for the Brazilian SME Green Value. Guilherme holds a Master and a Bachelor degree in Economic History from the University of Geneva and a Bachelor in Social Sciences from the Federal University of Minas Gerais, Brazil.
Morgane De Pol joined IFPMA in 2007 in the communications function. She develops and implements communications and public affairs programs that facilitate mutual understanding and dialogue between IFPMA and other global health actors. Morgane worked previously with MCI, a global communications and event management group, in its Pharma Unit. She holds a master’s degree in Languages and Literature from the University of Geneva and a post-graduate degree in Special Events Communication from the Advancia School in Paris.
Ms. Cyntia Genolet joined IFPMA in 2012 where she is responsible of the anti-counterfeiting portfolio. Cyntia also works on policy issues related to biotherapeutics and regulatory.
Prior to joining the IFPMA, Ms. Genolet has worked in Geneva for Sanofi in the Relations with International Institutions office. She previously accrued professional experience in Africa, South America and Switzerland for NGOs, international organizations and governments. She holds a MA in International Relations from the Graduate Institute of International and Development Studies in Geneva and a MAS in Health Economics and Management from HEC Lausanne.
Nina Grundmann joined IFPMA in June 2012 and focuses primarily on two disease areas (viral hepatitis and mental health) and on anti-microbial resistance. Nina has also worked on vaccine regulatory and programmatic policy and influenza vaccines. Prior to joining IFPMA, Nina worked at Sanofi Pasteur on vaccination policy and advocacy. Nina holds a master’s degree in International Affairs from the French Institute of Political Studies and a post-graduate degree in Risk Management from HEC Business School in Paris.
Sadia Kaenzig joined IFPMA in 2014 and is in charge of communications namely in the areas of biotherapeutic medicines and vaccines. She is driven by a constant need to change the way the world tackles global health challenges and find cost-effective solutions that tap the creativity, knowledge and assets of cross sector, public-private partnerships.
Prior to joining IFPMA, she mainly worked in for the International Red Cross (ICRC and IFRC), Drugs for Neglected Diseases initiative and the refugee agency UNHCR. Sadia holds a diploma degree in translations from Geneva University and a masters in international relations from the Graduate Institute of International and Development Studies.
Manager, Innovation, Intellectual Property and Trade
Ernest Kawka joined IFPMA in January 2013 and focuses his work on Intellectual Property and Trade. Prior to joining IFPMA, Ernest has held regulatory and legal positions in the pharmaceutical industry, including Sanofi Pasteur and Novo Nordisk. Ernest received his bachelor’s degree in biochemistry and a master’s in analytical chemistry. In addition, he holds a JD and is licensed to practice law in New Jersey and New York.
Minji Kwak joined IFPMA as Administrative Assistant in April 2015. She provides administrative support to staff and members of IFPMA, takes care of the logistics of meetings and events, updates the website, Extranet platform and database of IFPMA. Minji previously worked in International Telecommunication Union (ITU) as an Account Assistant. She holds a bachelor degree in International Languages and Cultures at Chiba University, Japan.
Caroline Mendy joined IFPMA in 2012 from the World Health Organization (WHO), where she held the position of Technical Officer in the Essential Medicines and Pharmaceutical Policies department (EMP), focusing on technical support to WHO Member States on quality control/assurance (QC/QA) of pharmaceutical products, and providing the Secretariat of the WHO Expert Committee on Specifications for Pharmaceutical Preparations.
Prior to WHO, Caroline worked at the Council of Europe, European Directorate for the Quality of Medicines and Healthcare (EDQM) in Strasbourg (France) as Scientific Administrator, focusing on the drafting and revision of European Pharmacopoeia (Ph.Eur) texts; and for 2 years at Pharmascience Inc. in Montreal (Canada) as Specifications and Drug Master Files (DMFs) Specialist. Caroline holds an M.Sc. in Biochemistry from the University of Paris VII (France), and an M.Sc. in Pharmaceutical Sciences - Drug Development from the Faculty of Pharmacy of University of Montreal (Canada).
Hiroko Nishimoto is Japan Liaison Executive at IFPMA where she has been working from May 2015. As a member of the global health team, she facilitates the communication between the IFPMA and Japanese Pharmaceutical Manufacturers Association (JPMA) on policy decisions and partnerships as she is seconded from the JPMA.
Prior to joining IFPMA, she has worked for Astellas Pharma Inc. for 12 years in Japan, most recently in its corporate planning function and has been engaged in CSR and project management for Astellas’ global health initiatives. Hiroko holds a MBA degree from Waseda Business School and a BA in English Literature from Doshisha University in Japan.
Director, Public Affairs, Communications & Global Health Policy
Mario Ottiglio is Director, Public Affairs, Communications & Global Health Policy at IFPMA where he has been working since 2007 in positions of increasing responsibility. Mario develops and leads the implementation of global health policies and designs public affairs strategies. He represents IFPMA in discussions with international organizations, governments and other nongovernmental organizations building consensus on policy decisions and partnerships. Prior to joining the IFPMA, Mario worked as a consultant for governments and private firms. He holds a Master’s degree in Political Science and International Relations from the Oriental Studies University of Naples.
Vanessa is Manager, Global Health Policy at IFPMA.
Prior to joining IFPMA, Vanessa was Senior Analyst at the Economist Intelligence Unit, where she was responsible for delivering economic, policy and business analysis and advisory services to clients across Europe, Middle East and Africa. Within this role, she also acted as healthcare liaison and was responsible for maintaining key client relationships with organizations within this sector. Prior to her role at the EIU, Vanessa was Senior Consultant at GHK Consulting, a public policy consultancy specializing in the evaluation of public projects and programs in the UK and Europe. She holds a Master’s degree in Development Studies from the London School of Economics and Political Science, and a Bachelor’s degree in Economics from University College London.
Laurent Renaud joined IFPMA in April 1994. He is responsible for the administration, finances and human resources. His tasks include the day to day management (book-keeping, account payable), liaison with the Geneva and Swiss administration; including work permit application and renewal process, social security, pension fund and tax issues and all other legal and/or statutory requirements.
Laurent’s previous positions include senior accounting position in two private hospitals and auditor at Société Fiduciaire Suisse-Coopers & Lybrand (now PWC).
Brendan Shaw is Assistant Director General at the IFPMA and was appointed in 2014. Brendan assists the Director General in leading on a range of policy and representational functions particularly in innovation policy, intellectual property, trade, health technology assessment, ethics, compliance and vaccines. Prior to joining the IFPMA, Brendan was Chief Executive of the Australian pharmaceutical industry association, Medicines Australia, and before that was the senior executive at MA in charge of health policy and research. Brendan has also worked as an economist and policy advisor in government and politics, in academia and as a consultant. Brendan holds an honours degree in economics from the University of Queensland and a PhD in management, business and economics from Monash University.
Margarita Xydia-Charmanta joined the IFPMA in June 2014 as Vaccines Policy Manager and is responsible for the IFPMA Influenza Vaccine Supply International Task Force (IVS TF) as well as vaccine regulatory and programmatic policy, norms and standards.
Prior to that, Margarita worked at the World Economic Forum on global health and healthcare issues, at AbbVie’s Greek affiliate in the Market Access department, and at the OECD Health Division. Margarita holds a Master’s degree in International Health Policy, with a focus on Health Economics, from the London School of Economics and Political Science, and a Bachelor of Science in Biochemistry from King’s College London.